Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 Nov;56(5):653–660. doi: 10.1038/bjc.1987.261

Early oral contraceptive use and breast cancer: results of another case-control study.

K McPherson 1, M P Vessey 1, A Neil 1, R Doll 1, L Jones 1, M Roberts 1
PMCID: PMC2001913  PMID: 3426932

Abstract

We report the results of a case-control study of oral contraceptive use and breast cancer conducted in London, Oxford and Edinburgh between 1980 and 1984. One thousand one hundred and twenty-five women aged 16-64 years with newly diagnosed breast cancer and a like number of matched controls were interviewed and asked about their past due use of oral contraceptives (OCs). Among women aged 45 years or more at diagnosis there was no evidence of an association between OC use and breast cancer. Among the 351 pairs of women aged under 45 years at diagnosis there was a significantly elevated risk associated with increasing duration of use before first full term pregnancy (relative risk for 4+ years use versus never use = 2.6, 95% confidence limits, 1.3-5.4). Since this result is at variance with the findings in some other studies we have investigated the nature of this association with particular emphasis on possible bias, pill type and a latent effect.

Full text

PDF
653

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armenian H. K., Lilienfeld A. M. Incubation period of disease. Epidemiol Rev. 1983;5:1–15. doi: 10.1093/oxfordjournals.epirev.a036254. [DOI] [PubMed] [Google Scholar]
  2. Bolt H. M., Bolt W. H. Pharmacokinetics of mestranol in man in relation to its oestrogenic activity. Eur J Clin Pharmacol. 1974 Jul 26;7(4):295–305. doi: 10.1007/BF00560348. [DOI] [PubMed] [Google Scholar]
  3. Coulter A., Vessey M., McPherson K., Crossley B. The ability of women to recall their oral contraceptive histories. Contraception. 1986 Feb;33(2):127–137. doi: 10.1016/0010-7824(86)90079-x. [DOI] [PubMed] [Google Scholar]
  4. Drife J. O. Breast cancer, pregnancy, and the pill. Br Med J (Clin Res Ed) 1981 Sep 19;283(6294):778–779. doi: 10.1136/bmj.283.6294.778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Greenberg E. R., Barnes A. B., Resseguie L., Barrett J. A., Burnside S., Lanza L. L., Neff R. K., Stevens M., Young R. H., Colton T. Breast cancer in mothers given diethylstilbestrol in pregnancy. N Engl J Med. 1984 Nov 29;311(22):1393–1398. doi: 10.1056/NEJM198411293112201. [DOI] [PubMed] [Google Scholar]
  6. Harris N. V., Weiss N. S., Francis A. M., Polissar L. Breast cancer in relation to patterns of oral contraceptive use. Am J Epidemiol. 1982 Oct;116(4):643–651. doi: 10.1093/oxfordjournals.aje.a113447. [DOI] [PubMed] [Google Scholar]
  7. Korenman S. G. Oestrogen window hypothesis of the aetiology of breast cancer. Lancet. 1980 Mar 29;1(8170):700–701. [PubMed] [Google Scholar]
  8. MacMahon B., Cole P., Brown J. Etiology of human breast cancer: a review. J Natl Cancer Inst. 1973 Jan;50(1):21–42. doi: 10.1093/jnci/50.1.21. [DOI] [PubMed] [Google Scholar]
  9. Mant D., Vessey M. P., Neil A., McPherson K., Jones L. Breast self examination and breast cancer stage at diagnosis. Br J Cancer. 1987 Feb;55(2):207–211. doi: 10.1038/bjc.1987.39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. McPherson K., Coope P. A., Vessey M. P. Early oral contraceptive use and breast cancer: theoretical effects of latency. J Epidemiol Community Health. 1986 Dec;40(4):289–294. doi: 10.1136/jech.40.4.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. McPherson K., Drife J. O. The pill and breast cancer: why the uncertainty? Br Med J (Clin Res Ed) 1986 Sep 20;293(6549):709–710. doi: 10.1136/bmj.293.6549.709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McPherson K., Neil A., Vessey M. P., Doll R. Oral contraceptives and breast cancer. Lancet. 1983 Dec 17;2(8364):1414–1415. doi: 10.1016/s0140-6736(83)90936-4. [DOI] [PubMed] [Google Scholar]
  13. Meirik O., Lund E., Adami H. O., Bergström R., Christoffersen T., Bergsjö P. Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway. Lancet. 1986 Sep 20;2(8508):650–654. doi: 10.1016/s0140-6736(86)90166-2. [DOI] [PubMed] [Google Scholar]
  14. Miller D. R., Rosenberg L., Kaufman D. W., Schottenfeld D., Stolley P. D., Shapiro S. Breast cancer risk in relation to early oral contraceptive use. Obstet Gynecol. 1986 Dec;68(6):863–868. [PubMed] [Google Scholar]
  15. Olsson H., Olsson M. L., Möller T. R., Ranstam J., Holm P. Oral contraceptive use and breast cancer in young women in Sweden. Lancet. 1985 Mar 30;1(8431):748–749. doi: 10.1016/s0140-6736(85)91280-2. [DOI] [PubMed] [Google Scholar]
  16. Orme M. L., Back D. J., Breckenridge A. M. Clinical pharmacokinetics of oral contraceptive steroids. Clin Pharmacokinet. 1983 Mar-Apr;8(2):95–136. doi: 10.2165/00003088-198308020-00001. [DOI] [PubMed] [Google Scholar]
  18. Paffenbarger R. S., Jr, Fasal E., Simmons M. E., Kampert J. B. Cancer risk as related to use of oral contraceptives during fertile years. Cancer. 1977 Apr;39(4 Suppl):1887–1891. doi: 10.1002/1097-0142(197704)39:4+<1887::aid-cncr2820390822>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  19. Paul C., Skegg D. C., Spears G. F., Kaldor J. M. Oral contraceptives and breast cancer: a national study. Br Med J (Clin Res Ed) 1986 Sep 20;293(6549):723–726. doi: 10.1136/bmj.293.6549.723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pike M. C., Henderson B. E., Casagrande J. T., Rosario I., Gray G. E. Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer. 1981 Jan;43(1):72–76. doi: 10.1038/bjc.1981.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pike M. C., Henderson B. E., Krailo M. D., Duke A., Roy S. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet. 1983 Oct 22;2(8356):926–930. doi: 10.1016/s0140-6736(83)90450-6. [DOI] [PubMed] [Google Scholar]
  22. Ranstam J., Olsson H. Oral contraceptives and breast cancer. Lancet. 1987 Mar 14;1(8533):636–636. doi: 10.1016/s0140-6736(87)90284-4. [DOI] [PubMed] [Google Scholar]
  23. Rosenberg L., Miller D. R., Kaufman D. W., Helmrich S. P., Stolley P. D., Schottenfeld D., Shapiro S. Breast cancer and oral contraceptive use. Am J Epidemiol. 1984 Feb;119(2):167–176. doi: 10.1093/oxfordjournals.aje.a113735. [DOI] [PubMed] [Google Scholar]
  24. Stadel B. V., Rubin G. L., Webster L. A., Schlesselman J. J., Wingo P. A. Oral contraceptives and breast cancer in young women. Lancet. 1985 Nov 2;2(8462):970–973. doi: 10.1016/s0140-6736(85)90524-0. [DOI] [PubMed] [Google Scholar]
  25. Tokunaga M., Norman J. E., Jr, Asano M., Tokuoka S., Ezaki H., Nishimori I., Tsuji Y. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74. J Natl Cancer Inst. 1979 Jun;62(6):1347–1359. [PubMed] [Google Scholar]
  26. Vessey M. P., McPherson K., Yeates D., Doll R. Oral contraceptive use and abortion before first term pregnancy in relation to breast cancer risk. Br J Cancer. 1982 Mar;45(3):327–331. doi: 10.1038/bjc.1982.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Vessey M., Baron J., Doll R., McPherson K., Yeates D. Oral contraceptives and breast cancer: final report of an epidemiological study. Br J Cancer. 1983 Apr;47(4):455–462. doi: 10.1038/bjc.1983.74. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES